HOME > TOP STORIES
TOP STORIES
-
REGULATORY Annual Price Revision Push Gaining Momentum; PM Wants Pricing Revamp Policy by Year-End
November 28, 2016
-
BUSINESS Drug Makers Concerned about Cost-Effective Assessments Used for NHI Price Cuts: Survey
November 28, 2016
-
REGULATORY Keytruda Clears MHLW Panel for Both 1st-Line, 2nd-Line NSCLC
November 25, 2016
-
BUSINESS 27 Japan Drug Makers Eke Out Profit despite Logging Lower Sales on FX, Price Cuts: Jiho Tally
November 24, 2016
-
REGULATORY MHLW to Announce Opdivo’s New Prices on Nov. 24
November 24, 2016
-
BUSINESS Taltz Finally Makes it to Japan Market after Pricing Flap
November 22, 2016
-
BUSINESS 3 Japan Generic Majors See Subdued Sales Rise in April-September
November 21, 2016
-
REGULATORY MHLW to Kick Off Discussions for Major Drug Pricing Overhaul by Year-End: Bureau Chief
November 18, 2016
-
REGULATORY 50% Price Cut for Opdivo OK’ed with Estimated Sales of 151.6-Plus Billion Yen
November 17, 2016
-
REGULATORY ICH Eyes Major GCP Revamp with Use of Real World Data: Osaka Confab
November 16, 2016
-
REGULATORY Opdivo’s NHI Price-Based Sales Put at Over 151 Billion Yen; 50% Cut Likely to Take Effect Feb. 1
November 15, 2016
-
TRENDS AGs Set to Break into 10 Billion Yen Territory in Japan
November 14, 2016
-
REGULATORY MHLW Panel to Discuss NSCLC Indication for Keytruda on Nov. 24
November 14, 2016
-
REGULATORY LDP Study Group on Biologics to Hold 1st Meeting on Nov. 24; Aims to Halt the Rush to Promote Biosimilars
November 11, 2016
-
BUSINESS Top 4 Wholesalers See Lower Sales in April-September If Hep C Meds Excluded
November 11, 2016
-
REGULATORY MHLW Plans 50% Price Cut for Opdivo
November 10, 2016
-
REGULATORY Chuikyo OKs Taltz, Micatrio for Listing on Nov. 18; Keytruda Takes Pass This Time
November 9, 2016
-
BUSINESS Current Drug Pricing System Became Unfit for New Drugs Like Opdivo: Ono Chief
November 8, 2016
-
BUSINESS MSD’s New Dual Oral Hep C Therapy to Challenge Harvoni; Effective Regardless of Resistance Mutations, Renal Impairment
November 8, 2016
-
ACADEMIA Draft Guidelines on Pneumonia Treatment Set Guides for Selecting Antibacterial Agents: Respiratory Society
November 7, 2016
ページ
1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…